Cyclin E2 Antikörper (N-Term)
Kurzübersicht für Cyclin E2 Antikörper (N-Term) (ABIN2792173)
Target
Alle Cyclin E2 (CCNE2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- TTQDVKKRRE EVTKKHQYEI RNCWPPVLSG GISPCIIIET PHKEIGTSDF
-
Homologie
- Cow: 100%, Guinea Pig: 84%, Horse: 100%, Human: 100%, Mouse: 91%, Pig: 92%, Rat: 91%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against CCNE2. It was validated on Western Blot using a cell lysate as a positive control.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human CCNE2
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 404 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Cyclin E2 (CCNE2)
-
Andere Bezeichnung
- CCNE2
-
Hintergrund
-
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit
Alias Symbols: CYCE2
Protein Interaction Partner: CDKN1A, CDK2, CDK3, ORC3, CDKN1C, CDKN1B, APP, HIST1H1A, UBC, PTEN, FBXW7, SUMO2, SUMO3,
Protein Size: 404 -
Molekulargewicht
- 47 kDa
-
Gen-ID
- 9134
-
NCBI Accession
- NM_057749, NP_477097
-
UniProt
- O96020
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-